Bayer CropScience, Precision BioSciences modify plant genomes using DNE technology

NewsGuard 100/100 Score

Precision BioSciences Inc., announced today that Bayer CropScience and Precision BioSciences have successfully modified plant genomes using Precision's Directed Nuclease EditorTM (DNE) technology.

During the initial research phase of the partnership, scientists at Bayer CropScience used a pair of engineered meganucleases produced by Precision to target the insertion and removal of DNA at two pre-determined locations in a plant genome.

Precision's DNE technology, which is based on the rational production of "custom" DNA-cleaving enzymes called "meganucleases," enables crop researchers to delete, insert, or otherwise modify genes at user-defined endogenous sites within plant genomes. By facilitating the direct introduction of favorable traits into plant species, the technology can streamline product development and reduce the time it takes to get a product to market.

Bayer CropScience has now elected to extend its research and commercial partnership with Precision BioSciences. Under this extended agreement, Precision BioSciences will be working with Bayer CropScience to develop additional DNE-engineered enzymes for use across the company's crop platforms.

Source:

Precision BioSciences Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Chatbots for mental health pose new challenges for US regulatory framework